SOLICITING DEALER AGREEMENT NYLIFE DISTRIBUTORS LLC NYLIM Center Parsippany, New Jersey 07054
NYLIFE
DISTRIBUTORS LLC
NYLIM
Center
000
Xxxxxxxxxx Xxxxxx
Xxxxxxxxxx, Xxx Xxxxxx
00000
Ladies
and Gentlemen:
We are
the principal underwriter of the open-end investment companies sponsored,
advised or administered by any affiliate of New York Life Investment Management
LLC (“NYLIM,” or series thereof, the “NYLIM Funds”) and/or we have agreements
with the principal underwriters of certain other open-end investment companies
(or series thereof, the “Other Funds” and, together with the NYLIM Funds, the
“Funds”) as referenced on the attached “Fund Schedule.” We hereby
offer to sell shares of the Funds (collectively the “Shares”) to you upon the
following terms and conditions:
1.
|
The
terms of the offering of the Shares are more fully described in the
current prospectus and statement of additional information for each Fund
(together, the “Prospectus”), receipt of which you hereby
acknowledge. You agree to abide by the terms of the Prospectus,
and to the extent that the Prospectus contains provisions that are
inconsistent with the terms of this Agreement the terms of the Prospectus
shall be controlling.
|
2.
|
You
hereby represent, warrant and covenant that you are, and shall remain,
duly and validly organized, validly existing and in good standing under
the laws of the state in which you are organized, with full and proper
power and authority to enter into and perform the terms of this
Agreement. You further covenant that the person signing on your
behalf is properly authorized to execute this Agreement and that this
Agreement constitutes a valid and binding contract between you and us,
enforceable in accordance with its
terms.
|
3.
|
You
represent and confirm that you and your registered principals are not
presently the subject of an action by any governmental, regulatory or
judicial authority and agree to promptly notify us in the event of any
such action. You also represent and warrant that for sales of
Shares to the public you and your agents and employees are and will remain
duly registered and licensed to offer and sell Shares in those
jurisdictions in which you do so. You will not offer the Funds
for sale in any state or other jurisdiction where they are not qualified
for sale or exempt from qualification under the laws and regulations of
such state or other jurisdiction. You further covenant that you
will promptly notify us of any change in your or your agents’ or
employees’ registered or licensed status in any jurisdiction in which you
or your agents or employees have been offering or selling
Shares.
|
4.
|
You
represent, warrant and covenant that you are registered as a broker-dealer
under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or that you are exempt from such registration, and that you are a
member of the Financial Industry Regulatory Authority, Inc. (“FINRA”), or
that you are exempt from FINRA membership. You agree that you
will immediately advise us of any termination or suspension of your
broker-dealer registration or FINRA membership or your exemption
therefrom.
|
5.
|
(a)
You agree to abide by the FINRA’s Conduct Rules, as well as all applicable
state and federal laws and rules and regulations of authorized regulatory
agencies thereunder, including all compensation disclosure obligations
imposed on you pursuant to FINRA Rule 2830 and Rule 10b-10 under the
Exchange Act. You agree not to offer or sell any Shares except
under circumstances that will result in compliance with such laws, rules
and regulations, including a review by you of the product’s suitability
for the customer, including the suitability of the class of Shares sold,
and compliance with any requirements regarding delivery of the Prospectus,
periodic reports, proxy solicitation materials and other Fund documents to
your customers investing in the relevant Funds. You
specifically agree not to permit any late trading or abusive short-term
trading in the Funds and agree to cooperate with the Funds in identifying
and restricting market timers. You agree to make sales of
Shares only to purchasers within the United
States.
|
1
(b) You
understand that the Funds are generally offered in more than one class of Shares
in accordance with each Fund’s Prospectus. You agree that you are
responsible for determining whether a Fund is suitable for your client and also
for determining which class of that Fund’s Shares is suitable for your
client.
(c) You
understand and agree that, pursuant to Rule 12b-1(h) under the Investment
Company Act of 1940, as amended (the “1940 Act”), the Funds will not compensate
you for any promotion or sale of Shares by directing to you (i) any portfolio
securities transactions of the Funds, or (ii) any remuneration received from the
Funds’ portfolio transactions effected through any other
broker-dealer.
6.
|
You
hereby represent that you are a member in good standing of the Mutual Fund
Settlement, Entry and Registration Verification (“Fund/SERV”) System of
the SCC Division of the National Securities Clearing Corporation (the
“NSCC”), authorized to utilize the Fund/SERV service in accordance with
the NSCC’s Rules and Regulations.
|
7.
|
It
is understood that nothing in this Agreement shall be construed to
establish a joint venture between us or establish either of us as an
agent, partner, or employee of the other, nor shall anything in this
Agreement be construed to establish you or any Fund or Plan as an agent,
partner or employee of the other. It is understood that you
have no authority to act as an agent for us or the Funds, except as
limited agent for the purpose of accepting orders from your
customers. You agree that all purchases of Shares from us shall
be made only to cover orders already received by you or for your own bona
fide investment. You agree that you will not withhold placing
customers’ orders for Shares so as to profit yourself as a result of such
withholding. We are not endorsing, recommending or otherwise
involved in any of your investment products involving the Funds, including
any Fee-Based Program (as may be defined in the Fund
Schedule).
|
8.
|
You
authorize and instruct us, the Funds, and our affiliates to accept, rely
upon and carry out instructions received from you or your affiliates with
respect to any purchase, redemption, exchange or other matter in
connection with your customers’ Fund or Plan accounts. All
orders for purchases of Shares received from you and accepted by us will
be at the public offering price applicable to each order, as established
by the relevant Prospectus. All orders for the purchase and
exchange of Shares accepted by you prior to the close of the New York
Stock Exchange (“NYSE”) (usually 4:00 p.m., Eastern time) must be
transmitted prior to the close of the NYSE. To the extent that
you transmit orders after the close of the NYSE for processing at that
day’s net asset value, you represent and warrant that any such order will
(a) have been placed by your customer prior to the close of the NYSE or
(b) be necessary to correct your error in processing a customer trade
properly placed prior to the close of the NYSE. All orders are
subject to acceptance by us in our sole discretion, and purchases become
effective only upon confirmation. The procedures relating to
the handling of orders shall be subject to instructions which we shall
advise you from time to time. We will not accept from you any
conditional orders for the purchase, sale or redemption of Shares, and you
agree that prior to execution of an application for a purchase of Shares
by a discretionary account, you will obtain (a) the prior written approval
of the purchaser, and (b) a record of the date on which this discretion
was granted.
|
9.
|
(a)
You agree that you will not purchase, as principal, any Shares from others
at a price lower than the redemption price next quoted by us as agent for
the Funds following receipt of the request for
redemption. Nothing in this Agreement, however, shall prevent
you from selling Shares for the account of a record owner to us or the
issuer at the redemption price next quoted by us as agent for the Funds
and charging the record owner a fair commission for handling the
transaction or reasonable fees to customers participating in a Fee-Based
Program.
|
2
(b) You
agree to provide to the Funds,
upon written request (“Request”) by the Funds or their designee, the following
information regarding every purchase, redemption, transfer, or exchange of
shares held through an account maintained by you during the period covered by
the request: (i) the taxpayer identification number (“TIN”) or social
security number, or the Individual/International Taxpayer Identification Number
(“ITIN”), or other government-issued identifier (“GII”), and account number, if
known, of any or all holders of shares (“Shareholder(s)”) of the account; (ii)
the gross transaction amount; the trade date and confirm date; (iii) the
broker-dealer name, broker-dealer number, branch code, representative name,
representative code, or other identifier of any investment professional(s)
associated with the Shareholder(s) or account (if known); (iv) the transaction
type (purchase, redemption, transfer, or exchange); and (v) the Fund name and
CUSIP symbol.
(b)(1) Requests must set forth a specific time
period, not to exceed 90 days from the date of the request, for which
transaction information is sought. We may request transaction information older
than 90 days from the date of the request as we deem necessary to investigate
compliance with policies established by the Funds for the purpose of eliminating
or reducing any dilution of the value of the outstanding shares issued by the
Funds.
(b)(2) You agree to provide, promptly upon
request of the Funds or their designee, the requested information specified
above in Section 9(b). If requested by the Funds or their designee,
you agree to use best efforts to determine promptly whether any specific person
about whom you have received the identification and transaction information
specified above in Section 9(b) is itself a financial intermediary (“indirect
intermediary”) and, upon further request of the Funds or
their designee, promptly either: (i) provide (or arrange to have
provided) to the Funds the requested information for Shareholders who hold an
account with an indirect intermediary; or (ii) restrict or prohibit the indirect
intermediary from purchasing Fund Shares in nominee name on behalf of other
persons. In such instance, you agree to inform the Funds whether you plan to
perform (i) or (ii). Responses required by this paragraph must be
communicated in writing and in a format mutually agreed upon by the
parties. To the extent practicable, the format for any transaction
information provided to the Funds should be consistent with the National
Securities Clearing Corporation Standardized Data Reporting
Format. For purposes of this provision, an “indirect intermediary”
has the same meaning as in SEC Rule 22c-2 under the Investment Company Act of
1940, as amended.
(b)(3) You agree to execute written
instructions from the Funds or their designee to restrict or prohibit further
purchases or exchanges of Shares by a Shareholder that has been identified by
the Funds or their designee as having engaged in transactions of the Fund’s
Shares (directly or indirectly through the your account) that violate policies
established by the Funds for the purpose of eliminating or reducing any dilution
of the value of the outstanding Shares issued by the Funds.
10.
|
(a)
In the case of any Fund shares sold with a front-end sales load, customers
may be entitled to a reduction in sales load on purchases made from a Fund
which utilizes a letter of intent (“Letter of Intent”) in accordance with
such Fund’s Prospectus. In such case, our dealer reallowance
will be paid based upon the reduced sales load, but adjustment to a higher
dealer reallowance will be made in accordance with the Prospectus of the
applicable Fund to reflect the investor’s actual purchases if he should
fail to fulfill his Letter of
Intent.
|
3
(b)
Subject to and in accordance with the terms of the Prospectus of each Fund sold
with a front-end sales load, a reduced sales load may be applicable with respect
to customer accounts through a right of accumulation under which customers are
permitted to purchase shares of a Fund at the then current public offering price
per share applicable to the total of (i) the dollar amount of shares then being
purchased plus (ii) an amount equal to the then current net asset value of the
customer’s combined holdings of the shares of such Fund and of any other
open-end registered investment companies as may be permitted by the applicable
Fund Prospectus. You agree to calculate the applicable front-end
sales load charged in connection with the sale of the Funds’ shares in
accordance with those rights of accumulation. In such case, we agree
to furnish to you if orders are made by wire, or to the transfer agent as such
term is defined in the Prospectus of each Fund (the “Transfer Agent”) if orders
are made by mail, sufficient information to permit your confirmation of
qualification for a reduced sales load; acceptance of the purchase order is
subject to such confirmation.
(c) With
respect to Fund shares sold with a front-end sales load, we agree to advise you
promptly at your request as to amounts of any and all sales by us qualifying for
a reduced sales load.
11.
|
Payment
for Shares ordered from us must be received by us within three business
days after our acceptance of your order, or within such shorter time as is
prescribed by the applicable Prospectus or federal securities
laws. If payment for the Shares is not so received by us, we
reserve the right, without notice, to cancel the sale without any
responsibility or liability on our part or on the part of the Funds, at
our option, to sell the Shares ordered back to the relevant Fund(s) (in
either case we may hold you responsible for any loss, including loss of
profit, suffered by us resulting from your failure to make payment as
aforesaid, including, if applicable, your failure to make payment in
accordance with the NSCC’s Rules and Regulations and any agreements
thereunder).
|
12.
|
You
agree that if any Shares sold to you by us under the terms of this
Agreement are tendered for redemption within seven business days after the
date of confirmation of the original purchase by you, you shall forfeit
your right to any compensation received by or allowed to you on the sale
of such Shares hereunder. We agree to notify you of any such
redemption within ten business days, and you agree to forthwith refund to
us the full discount or other compensation received by or allowed to
you.
|
13.
|
You
will be compensated in accordance with the attached “Fund Schedule” which,
anything herein to the contrary notwithstanding, is subject to change by
us at any time and from time to time, but no such changes shall affect
amounts payable to you on orders accepted by us prior to any such
changes. Service Fees or Distribution Fees (as indicated on the
Fund Schedule) will be paid quarterly at the applicable annual rate
indicated on the Fund Schedule and will be based on the average daily net
asset value of your customers’ Shares held during the
quarter. Amounts of less than $25 will not be
paid. In addition, you will not be paid any purchase
commissions on purchases resulting from the reinvestment of dividends or
distributions or any compensation on purchases of Shares of any money
market Fund.
|
14.
|
Neither
you nor any other person, including any person associated with you, is
authorized or permitted to give any information nor to make any
representations concerning the Shares or the Funds other than those
contained in the applicable Prospectus or any advertising material or
sales literature supplied or approved by us. You agree that you
will rely solely on the representations contained in the Prospectus and
aforementioned advertising material or sales literature when purchasing
Shares from us. Any supplemental sales literature, if
distributed, must be preceded or accompanied by the relevant Prospectus
currently in effect. Advertisements and sales literature
provided by us that are designated as being for broker-dealer use only may
not be disseminated to the public. You further agree that you
will not disseminate or publish any advertising material or sales
literature relating to your solicitation of purchases of Shares (a) which
has not been approved in writing in advance by us and (b) the form of
which has not been submitted to the
FINRA.
|
4
15.
|
You
will (a) provide us with reasonable access to your offices and
representatives and mutual fund and, if applicable, Fee-Based Program
sales support personnel and their meetings, including conference calls,
national and regional sales conferences and training programs on a regular
basis; and (b) include descriptions of the Funds in internal sales
materials and any electronic information displays; provided, that you will
not disseminate or publish any advertising material or sales literature
(including electronic media) relating to your solicitation of purchases of
Shares other than in accordance with this
Agreement.
|
16.
|
We
agree that additional copies of the Prospectus, periodic reports, proxy
solicitation materials, advertising material, sales literature, and
application forms for the purchase of Shares and other Fund or Plan
documents will be supplied by us to you in reasonable quantities upon
request.
|
17.
|
You
agree that the Funds shall have no liability or responsibility to you
regarding (a) any printed information furnished by us to you other than
the Prospectus, periodic reports and proxy solicitation materials, and (b)
qualifying the Shares for sale in the various
states.
|
18.
|
You
agree not to use the terms “Eclipse”; “MacKay Xxxxxxx”; “MainStay”;
“ICAP”; “New York Life”; “NYLIFE”; “NYLIM”; or the names of their
affiliates, or any combination thereof, or to make any other references to
a Fund, its adviser or principal underwriter, or a Plan whether in
writing, by radio or television, or through any other advertising media,
without our prior written approval.
|
19.
|
You
agree that we shall have full authority to take such action as we may deem
advisable in respect to all matters pertaining to the offering of Shares,
and we reserve the right, in our discretion, to suspend sales or withdraw
the offering of Shares entirely without prior notice to you. We
shall be under no liability to you except for lack of good faith in
performing our obligations expressly assumed by us in this Agreement and
liabilities under Section 11(f) of the Securities Act of 1933, as amended
(the “Securities Act”), and no obligations on our part shall be implied or
inferred from this Agreement.
|
20.
|
(a)
You shall reimburse, indemnify and hold harmless us, our directors,
officers, employees, agents and affiliates for any direct or indirect
liability, loss, actual and compensatory damages, and expense (including
reasonable attorneys’ fees and costs) arising directly or indirectly out
of: (i) the acts or omissions of you or your registered agents or
employees, including the unauthorized use of advertising materials or
sales literature, misrepresentations or omissions, unlawful sales
practices, failure to supervise or violation of any applicable laws, rules
and regulations, including, but not limited to, those of the SEC, FINRA
and the NSCC; (ii) any breach of the representations, warranties,
conditions or other provisions of this Agreement; (iii) claims by
your agents or employees for any type of remuneration or compensation;
(iv) the payment of redemption proceeds for your customers’ Shares; (v)
any claims in connection with your failure to comply with the forward
pricing requirements of Rule 22c-1 under the 1940 Act; and
(vi) any claims in connection with late trading or market timing
transactions effected through you on an other than fully-disclosed
basis. This right of indemnification will survive the
termination of this Agreement.
|
(b) We
shall reimburse, indemnify and hold harmless you, your directors, officers,
employees, agents and affiliates for any direct or indirect liability, loss,
actual and compensatory damages, and expense (including reasonable attorneys’
fees and costs) arising directly or indirectly out of: (i) the acts
or omissions of us or our registered agents or employees, including violation of
any applicable laws, rules and regulations, including, but not limited to, those
of the SEC, FINRA and the NSCC; (ii) any breach of the representations,
warranties, conditions or other provisions of this Agreement; or (iii) any
untrue statement of a material fact contained in any Fund’s registration
statement or any offering documents, or any omission to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading. This right of indemnification will survive the
termination of this Agreement.
5
(c) Each
party hereto agrees to notify the other party within a reasonable time of any
claims which might involve liability on the part of the other
party.
21.
|
The
Fund Schedule is incorporated by reference into and made a part of this
Agreement. We agree that this Agreement shall be governed by
and construed in accordance with the laws of the state of New York and
that all disputes among the parties to this Agreement shall be submitted
to arbitration in accordance with the FINRA’s Code of Arbitration
Procedure or successor thereto in effect at the time. If any
provision of this Agreement shall be held or made invalid by a statute,
rule, regulation, decision of a tribunal or otherwise, the remainder of
this Agreement shall not be affected thereby and, to this extent, the
provisions of this Agreement shall be deemed to be
severable.
|
22.
|
You
and we agree that during the term of this Agreement a party to this
Agreement (“Receiving Party”) may receive or have been given access to
certain confidential or proprietary information and/or intellectual
property or may have or be given access to such information and/or
property of the other party (“Disclosing Party”) (collectively,
“Confidential Information”). Confidential Information shall
mean any and all information, in whatever form or media, including without
limitation business and marketing plans, financial records and customer
information, unless such information is or becomes publicly
available. Receiving Party will not use Confidential
Information other than for the purposes of this Agreement and agrees that
it will not, without prior written consent of Disclosing Party, disclose
Confidential Information to any party other than its employees, directors
and officers as necessary to perform this Agreement. Receiving
Party shall use best efforts to secure Confidential Information to
maintain its confidentiality and integrity and shall cause its employees,
officers and directors to whom Confidential Information is disclosed to be
informed of and agree to be bound by this provision and any privacy and
security guidelines provided by Disclosing Party. If Receiving
Party is requested by a court, administrative agency or governmental body
to disclose Confidential Information, Receiving Party will promptly notify
Disclosing Party in writing (unless Receiving Party reasonably believes
that notification is prohibited by the request) so that Disclosing Party
may seek an appropriate protective order or waive in writing Receiving
Party’s compliance with the provisions of this
Agreement. Receiving Party understands and acknowledges that
Disclosing Party may sustain irreparable harm as a result of disclosure of
Confidential Information. Accordingly, in the event of a breach
or threatened breach of this provision, Disclosing Party shall be entitled
to preliminary and permanent injunctive relief to preserve its rights
hereunder, in addition to any other available action or
remedy. Each party or its duly authorized agent will have the
right under this Agreement to perform on-site audits of records, accounts
and procedures directly pertaining to this Agreement at such party’s
facilities in accordance with reasonable procedures and at reasonable
frequencies. Upon the earlier of (a) a request of Disclosing
Party or (b) the termination of this Agreement, Receiving Party will
return all Confidential Information disclosed to it, in whatever form or
media, retaining no copies other than as necessary for it to comply with
applicable law.
|
23.
|
Notwithstanding
any provision herein to the contrary, each party hereto agrees that any
Nonpublic Personal Information, as defined under Section 248.3(t) of
Regulation S-P (“Regulation S-P”), promulgated under the
Xxxxx-Xxxxx-Xxxxxx Act (the “Act”), disclosed by a party hereunder is for
the specific purpose of permitting the other party to perform the services
set forth in this Agreement. Each party agrees that, with
respect to such information, it will comply with Regulation S-P and the
Act and that it will not disclose any Nonpublic Personal Information
received in connection with this Agreement to any other party, except to
the extent as necessary to carry out the services set forth in this
Agreement or as otherwise permitted by Regulation S-P or the
Act.
|
6
24.
|
This
Agreement may only be amended or waived by a writing signed by both
parties. Notwithstanding the foregoing, we reserve the right to
amend this Agreement and the Fund Schedule at any time, and you agree that
your submission of an order to purchase Shares after written notice of any
such amendment has been sent to you shall constitute your agreement to
such amendment. This Agreement shall not be assigned by you
without our written consent.
|
25.
|
Notices
to be given shall be addressed as follows, unless the party to whom notice
is to be given has specified an alternative means of
notification: (a) if to us, to the address specified
above, Attention: President,
with a copy to Xxxxxxxxxx Xxxxxxxx, Esq. at the same address; and
(b) if to you, to the address filled in by you
below.
|
26.
|
Notwithstanding
Section 28 below, you agree that if your compensation pursuant to this
Agreement is subject (as indicated on the Fund Schedule) to a plan adopted
pursuant to Rule
12b-1 (the “Rule 12b-1 Plan”) under the 1940 Act, that this Agreement: (a)
will only renew each year so long as such renewal is approved by a vote of
the governing board of each Fund (including a majority of the
“non-interested” board members (as defined in the 0000 Xxx) who have no
direct or indirect financial interest in the operation of the Rule 12b-1
Plan or this Agreement (“Independent Board Members”), (b) may be
terminated at any time, without the payment of any penalty, by vote of a
majority of the Independent Board Members, (c) may be terminated by vote
of a majority of the outstanding voting securities (as defined in the 0000
Xxx) of the Fund on not more than 60 days’ written notice, and (d) will
automatically terminate upon its assignment. Furthermore, you
understand that the Funds’ governing boards will review, at least
quarterly, a written report of the amounts expended pursuant to this
Agreement and the purposes for which such expenditures were
made. In connection with such reviews, you will furnish such
information as we or they may reasonably
request.
|
27.
|
You
represent and warrant that you have adopted and implemented anti-money
laundering policies, procedures and controls that comply and will continue
to comply in all respects with the requirements of applicable United
States anti-money laundering laws and regulations and those in your home
country jurisdiction. You will at all times during your
relationship with us strictly adhere to your anti-money laundering
policies, procedures and controls. You agree to cooperate with
us to satisfy our anti-money laundering due diligence policies, which may
include annual anti-money laundering compliance certifications, periodic
anti-money laundering due diligence reviews and/or other requests deemed
necessary to ensure your compliance with the anti-money laundering laws
and regulations.
|
28.
|
The
terms of this Agreement shall continue in force until terminated by a
party upon 30 days’ written notice to the other
party. Notwithstanding the foregoing, we shall have the right
to terminate this Agreement, without prior notice to you,
if:
|
|
(a)
|
you
or any of your registered principals become the subject of any
investigation or disciplinary action by any governmental, regulatory or
judicial authority that has resulted, or for which it appears reasonably
likely will result, in the loss or suspension of any registration,
membership or license referred to in this
Agreement;
|
7
|
(b)
|
your
ability to perform your obligations under this Agreement have become or
are reasonably likely to become impaired;
or
|
|
(c)
|
you
otherwise breach any of the representations and warranties set forth in
this Agreement. Upon termination of this Agreement, all authorizations,
rights and obligations shall cease except those contained in Sections 11,
18, 19, 20, and 22.
|
NYLIFE
DISTRIBUTORS LLC
|
||
By:
|
||
Title
|
||
Date
|
||
ACCEPTED:
|
||
Firm
Name
|
||
Address
|
||
By:
|
||
Title
|
||
Date
|
8
FUND
SCHEDULE
The terms of this Agreement shall apply
to the available series and classes of open-end investment companies sponsored,
advised or administered by New York Life Investment Management LLC for which
NYLIFE Distributors LLC serves as principal underwriter. Compensation for the
sale and/or servicing of such shares shall be in accordance with the terms of
the current prospectus and the following table:
Class
|
Dealer
Reallowance on Purchases1
|
Distribution
and/or Service (Rule 12b-1 Plan) Fees
|
Finder’s
Fee on Initial Purchases of $1,000,000 or more
|
Investor
Class
|
As
provided in current prospectus/statement of additional
information
|
0.25%
per annum2
|
N/A
|
A
|
As
provided in current prospectus/statement of additional
information
|
0.25%
per annum2
|
1.00%
on portion of sale from $1,000,000 to $2,999,999
0.50%
on portion of sale from $3,000,000 to $4,999,999
0.40%
on portion of sale of $5,000,000 or more.
Except
for the S&P 500 Index Fund, Indexed Bond Fund, and Short Term Bond
Fund, which pay as follows:
0.50%
on portion of sale from $1,000,000 to $2,999,999
0.25%
on portion of sale from $3,000,000 to $4,999,999
0.20%
on portion of sale of $5,000,000 or more
|
B
|
4.00%
of offering price
|
0.25%
per annum2
|
N/A
|
C
|
1.00%
of offering price
|
1.00%* per annum 2
|
N/A
|
I
|
N/A
|
N/A
|
As
provided in current prospectus/statement of additional
information
|
X0**
|
X/X
|
X/X
|
X/X
|
X0**
|
X/X
|
0.25%
per annum
|
N/A
|
R3**
|
N/A
|
0.50%
per annum
|
N/A
|
Notwithstanding
the foregoing, for sales through Fee-Based Programs:
|
·
|
You
will sell Class I shares or Class A shares of the Funds at net asset value
(without a sales charge) in a fee-based program made available to your
customers (the “Fee-Based
Program”).
|
|
·
|
If
Class A shares, you will be paid Distribution Fees at a rate of 0.25% per
annum, subject to continued effectiveness of the Fund’s Rule 12b-1
Plan.
|
|
·
|
No
fees will be paid on Class I
shares.
|
1 Initial purchases of less than
$1,000,000 or subsequent purchases in an account with a balance less than
$1,000,000.
2 After commissionable sales are held in
a shareholder’s account for one year or more. Payment is subject to
continued effectiveness of the Fund’s Rule 12b-1 Plan.
* 0.50% for Tax-Free Bond Fund Class
C.
** Under the terms of certain
Funds’ shareholder services plans, Class R1, R2 and R3 shares are authorized to
pay shareholder service fees to
service
providers at the rate of 0.10% per annum. Such fees are for services
that are in addition to any services that may be provided under the
Class R2
and R3 Rule 12b-1 Plans.
9